Wu Q - Search Results

1

Exploring Glypican-3 targeted CAR-NK treatment and potential therapy resistance in hepatocellular carcinoma.

Yang L, Pham K, Xi Y, Wu Q, Liu D, Robertson KD, Liu C. Yang L, et al. Among authors: wu q. PLoS One. 2025 Jan 22;20(1):e0317401. doi: 10.1371/journal.pone.0317401. eCollection 2025. PLoS One. 2025. PMID: 39841705 Free PMC article.

2

A Novel Vaccine Targeting Glypican-3 as a Treatment for Hepatocellular Carcinoma.

Wu Q, Pi L, Le Trinh T, Zuo C, Xia M, Jiao Y, Hou Z, Jo S, Puszyk W, Pham K, Nelson DR, Robertson K, Ostrov D, Rameshwar P, Xia CQ, Liu C. Wu Q, et al. Mol Ther. 2017 Oct 4;25(10):2299-2308. doi: 10.1016/j.ymthe.2017.08.005. Epub 2017 Aug 10. Mol Ther. 2017. PMID: 28865999 Free PMC article.

3

A Synthetic Aptamer-Drug Adduct for Targeted Liver Cancer Therapy.

Trinh TL, Zhu G, Xiao X, Puszyk W, Sefah K, Wu Q, Tan W, Liu C. Trinh TL, et al. Among authors: wu q. PLoS One. 2015 Nov 2;10(11):e0136673. doi: 10.1371/journal.pone.0136673. eCollection 2015. PLoS One. 2015. PMID: 26523833 Free PMC article.

4

Integrating the Epigenome to Identify Drivers of Hepatocellular Carcinoma.

Hlady RA, Sathyanarayan A, Thompson JJ, Zhou D, Wu Q, Pham K, Lee JH, Liu C, Robertson KD. Hlady RA, et al. Among authors: wu q. Hepatology. 2019 Feb;69(2):639-652. doi: 10.1002/hep.30211. Epub 2019 Jan 5. Hepatology. 2019. PMID: 30136421 Free PMC article.

5

Enhancement of sorafenib-mediated death of Hepatocellular carcinoma cells by Carnosic acid and Vitamin D2 analog combination.

Wu Q, Wang X, Pham K, Luna A, Studzinski GP, Liu C. Wu Q, et al. J Steroid Biochem Mol Biol. 2020 Mar;197:105524. doi: 10.1016/j.jsbmb.2019.105524. Epub 2019 Nov 5. J Steroid Biochem Mol Biol. 2020. PMID: 31704246 Free PMC article.

6

Interferon drives HCV scarring of the epigenome and creates targetable vulnerabilities following viral clearance.

Hlady RA, Zhao X, El Khoury LY, Luna A, Pham K, Wu Q, Lee JH, Pyrsopoulos NT, Liu C, Robertson KD. Hlady RA, et al. Among authors: wu q. Hepatology. 2022 Apr;75(4):983-996. doi: 10.1002/hep.32111. Epub 2021 Dec 15. Hepatology. 2022. PMID: 34387871 Free PMC article.

7

MiRNA-545 negatively regulates the oncogenic activity of EMS1 in gastric cancer.

Ma M, Zhao J, Wu Q, Xiao K, Li S, Zhu H, Liu C, Xie H, Zuo C. Ma M, et al. Among authors: wu q. Cancer Med. 2018 Jun;7(6):2452-2462. doi: 10.1002/cam4.1520. Epub 2018 May 7. Cancer Med. 2018. PMID: 29733519 Free PMC article.

8

Interferon-α and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma.

Zuo C, Qiu X, Liu N, Yang D, Xia M, Liu J, Wang X, Zhu H, Xie H, Dan H, Li Q, Wu Q, Burns M, Liu C. Zuo C, et al. Among authors: wu q. Exp Cell Res. 2015 May 1;333(2):316-326. doi: 10.1016/j.yexcr.2015.02.013. Epub 2015 Feb 24. Exp Cell Res. 2015. PMID: 25724899 Free article.

9

Members of the Cyr61/CTGF/NOV Protein Family: Emerging Players in Hepatic Progenitor Cell Activation and Intrahepatic Cholangiocarcinoma.

Wu Q, Jorgensen M, Song J, Zhou J, Liu C, Pi L. Wu Q, et al. Gastroenterol Res Pract. 2016;2016:2313850. doi: 10.1155/2016/2313850. Epub 2016 Oct 18. Gastroenterol Res Pract. 2016. PMID: 27829832 Free PMC article.

10

Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review).

Zuo C, Xia M, Wu Q, Zhu H, Liu J, Liu C. Zuo C, et al. Among authors: wu q. Oncol Lett. 2015 Feb;9(2):527-534. doi: 10.3892/ol.2014.2727. Epub 2014 Nov 21. Oncol Lett. 2015. PMID: 25624883 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,684 results

Search Page

Filters